Harm reduction strategies, support programs and better medications are contributing to the continuing decrease in HIV transmission among B.C.’s intravenous drug users, according to a report recently released by the Ministry of Health.
The report cited the Highly Active Anti-retroviral Therapy (HAART) as one likely contributor to the lower transmission rates.
HAART is a drug cocktail which slows the reproduction of the virus in patients and lowering their viral load to “undetectable” levels. Someone with an undetectable viral load is significantly less likely to transmit the virus to another person through body fluids. The report says that early diagnosis of HIV and quick uptake of HAART in intravenous drug users is helping to reduce the spread of the virus among users.
Read more: The Vancouver Courier